BRIEF—Big Data: Prescription for the pharmaceutical R&D plight

Toptal, a US firm that provides freelance software engineers, designers, and finance experts to companies, has just published a post on its blog addressing ‘Big data’ and the pharmaceutical industry, noting that pharma R&D is a notoriously long and arduous process, and it can take more than 10 years and $2.6 billion to bring a single drug to market.

Among the biggest players, the return on investment for R&D fell to 3.7% in 2016, says Melissa Lin, finance editor at Toptal.

However, a solution could be data analytics, which enhances and accelerates drug development.

This article examines the current state of drug development, and how big data can improve its different components: drug discovery, clinical trial design, and adverse drug reaction detection,” says Ms Lin.

The link to the article is here: https://www.toptal.com/insights/innovation/pharmaceutical-r-and-d-big-data